Skip to main content
. 2022 Jun 10;12:9640. doi: 10.1038/s41598-022-13753-6

Figure 1.

Figure 1

Improvements of colitis symptoms in mice via co-administration of L. gasseri KBL697 and Infliximab (IFX). (a,b) Body weights and DAI scores measured during experimental period. (c,d) Colon lengths and histology scores. (e) MPO levels. Statistical analysis was performed using one-way ANOVA with Dunnett’s post hoc test (*P < 0.05; **P < 0.01; ***P < 0.001).